Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125032982 | 12503298 | 2 | F | 2016 | 20160704 | 20160628 | 20160713 | EXP | GB-MHRA-ADR 23519928 | GB-ACCORD-041784 | ACCORD | 42.00 | YR | F | Y | 0.00000 | 20160713 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125032982 | 12503298 | 1 | PS | DOCETAXEL. | DOCETAXEL | 1 | 3 CYCLE | U | 201195 | ||||||||||
| 125032982 | 12503298 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | U | 40743 | Q3W | ||||||||||
| 125032982 | 12503298 | 3 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | U | 11811 | |||||||||||
| 125032982 | 12503298 | 4 | SS | ONDANSETRON | ONDANSETRON | 1 | U | 206846 | |||||||||||
| 125032982 | 12503298 | 5 | SS | EPIRUBICIN | EPIRUBICIN | 1 | U | 2147483647 | |||||||||||
| 125032982 | 12503298 | 6 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 24 HOURS AFTER CHEMOTHERAPY | U | 0 | 6 | MG | |||||||
| 125032982 | 12503298 | 7 | SS | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) | U | 0 | 80 | MG | QD | ||||||
| 125032982 | 12503298 | 8 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2 MG, ONCE DAILY, 3 DAYS | U | 0 | 2 | MG | QD | ||||||
| 125032982 | 12503298 | 9 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | U | 0 | |||||||||||
| 125032982 | 12503298 | 10 | SS | CYCLOPHOSPHAMIDE/CYCLOPHOSPHAMIDE MONOHYDRATE | CYCLOPHOSPHAMIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125032982 | 12503298 | 1 | Product used for unknown indication |
| 125032982 | 12503298 | 2 | Product used for unknown indication |
| 125032982 | 12503298 | 3 | Product used for unknown indication |
| 125032982 | 12503298 | 4 | Product used for unknown indication |
| 125032982 | 12503298 | 5 | Product used for unknown indication |
| 125032982 | 12503298 | 6 | Product used for unknown indication |
| 125032982 | 12503298 | 7 | Product used for unknown indication |
| 125032982 | 12503298 | 8 | Product used for unknown indication |
| 125032982 | 12503298 | 9 | Product used for unknown indication |
| 125032982 | 12503298 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125032982 | 12503298 | OT |
| 125032982 | 12503298 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125032982 | 12503298 | Arthralgia | |
| 125032982 | 12503298 | Constipation | |
| 125032982 | 12503298 | Decreased appetite | |
| 125032982 | 12503298 | Deep vein thrombosis | |
| 125032982 | 12503298 | Fatigue | |
| 125032982 | 12503298 | Oral pain | |
| 125032982 | 12503298 | Pain | |
| 125032982 | 12503298 | Vascular pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |